Medicare Enrolled

Dr. Samir Macwan, M.D.

Neurology · Rancho Mirage, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
72780 COUNTRY CLUB DR STE 205, Rancho Mirage, CA 92270
7608343540
In practice since 2007 (19 years)
NPI: 1265558753 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Macwan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Macwan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Macwan

Dr. Samir Macwan is a neurology specialist in Rancho Mirage, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Macwan performed 3,332 Medicare services across 2,200 unique beneficiaries.

Between the years covered by Open Payments, Dr. Macwan received a total of $839,708 from 38 pharmaceutical and/or device companies across 1445 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Macwan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 17% volume in CA $839,708 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,332
Medicare services
Top 17% in CA for neurology
2,200
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~175 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
841 $35 $145
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
475 $77 $192
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
348 $104 $320
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
258 $94 $189
Chemical nerve block for neck muscles
Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box.
215 $120 $236
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
199 $62 $118
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 180 $16 $53
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
173 $105 $199
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
136 $52 $121
Chemical nerve block injection, trunk muscles
An injection of a chemical agent to temporarily paralyze specific muscles in the trunk area. The procedure involves treating between one and five muscles.
128 $50 $155
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
80 $105 $277
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
62 $25 $94
Chemical nerve block injection, 5+ arm/leg muscles
Injection of a chemical agent to paralyze five or more muscles in the first extremity treated.
55 $87 $182
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
47 $150 $282
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
38 $86 $161
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
37 $129 $230
New patient office visit, complex (60-74 min) 21 $120 $426
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
15 $47 $174
Nerve-muscle junction testing
A diagnostic test used to evaluate the function of the connection between nerves and muscles.
12 $27 $46
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
12 $69 $191
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$839,708
Total received (2018-2024)
Avg $119,958/year across 7 years
Top 1% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
1,445
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$819,718 (97.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$15,469 (1.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,521 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$255,900
2023
$143,013
2022
$126,267
2021
$69,392
2020
$55,144
2019
$128,305
2018
$61,688

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ARGENX US, INC.
$103,462
UCB, Inc.
$56,605
ABBVIE INC.
$49,382
Alexion Pharmaceuticals, Inc.
$26,461
Grifols USA, LLC
$17,492
Janssen Scientific Affairs, LLC
$1,407
Ipsen Biopharmaceuticals, Inc
$262
Octapharma USA, Inc.
$167
Amylyx Pharmaceuticals, Inc.
$152
Genentech USA, Inc.
$125
Alnylam Pharmaceuticals Inc.
$118
CSL Behring
$107
Takeda Pharmaceuticals U.S.A., Inc.
$103
CATALYST PHARMACEUTICALS, INC.
$39
Amicus Therapeutics, Inc.
$17
Top 3 companies account for 81.8% of 2024 payments
All-time payments by company (2018-2024) ›
Alexion Pharmaceuticals, Inc.
$183,708
ARGENX US, INC.
$154,083
ABBVIE INC.
$135,880
UCB, Inc.
$106,930
US WorldMeds, LLC
$79,169
Allergan, Inc.
$54,627
Grifols USA, LLC
$50,251
Allergan Inc.
$29,447
AbbVie Inc.
$10,116
MDD US Operations, LLC
$9,739
CATALYST PHARMACEUTICALS, INC.
$8,860
Biohaven Pharmaceuticals, Inc.
$6,535
Biohaven Pharmaceutical Holding Company Ltd.
$2,343
Akcea Therapeutics, Inc.
$1,825
Janssen Scientific Affairs, LLC
$1,560
Grifols Shared Services North America, Inc.
$973
Octapharma USA, Inc.
$624
Ipsen Biopharmaceuticals, Inc
$507
UCB SA
$360
Lundbeck LLC
$278
Alnylam Pharmaceuticals Inc.
$239
Takeda Pharmaceuticals U.S.A., Inc.
$228
CSL Behring
$201
Amylyx Pharmaceuticals, Inc.
$152
Horizon Therapeutics plc
$149
Abbott Laboratories
$143
EMD Serono, Inc.
$125
Genentech USA, Inc.
$125
Biogen, Inc.
$123
GENZYME CORPORATION
$118
IMPEL PHARMACEUTICALS INC.
$115
Lilly USA, LLC
$97
Merz North America, Inc.
$25
SK Life Science, Inc.
$18
Amicus Therapeutics, Inc.
$17
Bio Products Laboratory USA, Inc.
$11
Travere Therapeutics, Inc.
$4
Retrophin, Inc.
$1
Top 3 companies account for 56.4% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · AGAMREE · AMVUTTRA · APOKYN · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · Cholbam · Dysport · FIRDAPSE · GAMMAGARD LIQUID · Gammaplex · Gamunex-C · HYQVIA · Hizentra · Infinity DBS Pulse Generators · LUMIZYME · MAVENCLAD · MYOBLOC · NURTEC ODT · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Ocrevus · PANZYGA · Pombiliti · Ponvory · QULIPTA · RELYVRIO · Rystiggo · SOLIRIS · SPINRAZA · Soliris · TEPEZZA · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · Ultomiris · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XCOPRI · XEOMIN · Xadago · Xembify · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in CA.

Looking for a neurology specialist in Rancho Mirage?
Compare neurologists in the Rancho Mirage area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
22
Per 100K population
0.9
County median income
$89,672
Nearest hospital
EISENHOWER MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Macwan is a clinical cardiology specialist, with above-average Medicare volume (top 17% in CA), with speaking/promotional industry engagement in the top 1% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Macwan experienced with electromyography of arm or leg muscles?
Based on Medicare claims data, Dr. Macwan performed 841 electromyography of arm or leg muscles services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Macwan receive payments from pharmaceutical companies?
Yes. Dr. Macwan received a total of $839,708 from 38 companies across 1,445 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Macwan's costs compare to other neurologists in Rancho Mirage?
Dr. Macwan's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Macwan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →